---
title: "NB KBE: Invests 5 million yen to establish a subsidiary in Japan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241958411.md"
description: "NB KBE announced that the company has invested 5 million Japanese yen to establish a wholly-owned subsidiary, NB KBE Electric Co., Ltd. Recently, the company has completed the registration procedures for the Japanese subsidiary and obtained the certificate of incorporation. The registered capital of the Japanese subsidiary is 5 million Japanese yen, and its registered address is located in Kawaguchi City, Saitama Prefecture"
datetime: "2025-05-27T08:07:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241958411.md)
  - [en](https://longbridge.com/en/news/241958411.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241958411.md)
---

# NB KBE: Invests 5 million yen to establish a subsidiary in Japan

NB KBE announced that the company has invested 5 million Japanese yen using its own funds to establish a wholly-owned subsidiary, NB KBE Electric Co., Ltd. Recently, the company has completed the registration procedures for the Japanese subsidiary and obtained the certificate of company registration. The registered capital of the Japanese subsidiary is 5 million Japanese yen, and its registered address is located in Kawaguchi City, Saitama Prefecture

### Related Stocks

- [300863.CN](https://longbridge.com/en/quote/300863.CN.md)

## Related News & Research

- [Cocoa Prices Sink as the Global Supply Outlook Improves](https://longbridge.com/en/news/286797386.md)
- [Here's Why FSN E-Commerce Ventures (NSE:NYKAA) Has Caught The Eye Of Investors](https://longbridge.com/en/news/286881823.md)
- [ZAWYA: Qatar Tourism launches service excellence training for MoI immigration officers in collaboration with HIA](https://longbridge.com/en/news/286757769.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [Orion Pharma to reveal initial results from Phase 1/2 TEADES study of ODM-212 at 2026 ASCO® Meeting.](https://longbridge.com/en/news/287177935.md)